Whole lung lavage
| Whole lung lavage | |
|---|---|
| Other names | Lung washing |
| ICD-9-CM | 33.99 |
Whole lung lavage (WLL), also called lung washing, is a medical procedure in which the patient's lungs are washed with saline (salt water) by filling and draining repeatedly. It is used to treat pulmonary alveolar proteinosis, in which excess lung surfactant proteins prevent the patient from breathing.[1][2] Some sources consider it a variation of bronchoalveolar lavage.[3]
WLL has been experimentally used for silicosis,[4] other forms of mineral inhalation, and accidental inhalation of radioactive dust.[5] It appears to effectively remove these foreign particles.[4][6] WLL treatments may slow down the lung function decline of miners with pneumoconiosis.[7]
Medical uses
[edit]
Whole lung lavage (WLL) is primarily used for treating conditions like pulmonary alveolar proteinosis (PAP), where it helps remove accumulated surfactant proteins from the lungs.[8] However, its application extends to other respiratory conditions, including Acute Respiratory Distress Syndrome (ARDS).In the context of ARDS, whole lung lavage has been explored as a treatment method, especially in experimental models. Studies have shown that WLL can be used to deplete surfactant, followed by the administration of surfactant replacement therapies. This approach helps improve lung function and oxygenation in conditions like neonatal ARDS.WLL is not a standard treatment for ARDS but is used in research settings to model and study ARDS treatment strategies. The primary goal in these scenarios is to understand how surfactant therapy and mechanical ventilation strategies can be optimized to treat ARDS more effectively.[9]
Procedure and technique
[edit]WLL is not a standardized procedure. Patients are usually first put under general anesthesia. A double lumen endotracheal tube is used to keep one lung breathing while the other is being washed. The lung to be washed is filled with fluid by gravity, then drained. Drainage can be done by suction[2] or gravity.[10] Some versions add a shaking step between the filling and draining to help with the washing.[2] The procedure typically uses 10–20 liters of fluid per patient, but severe cases require up to 50.[2]
Variations on the WLL include a "mini-WLL" with reduced infusion volume.[11] Reducing the suction power seems to reduce lung injury.[12]
Solutions
[edit]
The primary solution used in WLL is a sterile, isotonic saline solution. This solution closely matches the osmolarity of body fluids, making it gentle on the lung tissues. The saline serves several purposes. It helps dissolve the surfactant and proteinaceous material deposited in the alveoli, facilitating its removal from the lungs.Saline instillation helps maintain lung expansion during the lavage process, preventing atelectasis (collapse of lung tissue). The total volume of saline used can vary but typically ranges from 15 to 20 liters per lung, administered in aliquots of 500 to 1000 ml. Exogenous surfactant may be administered to help restore normal lung function after lavage.[13]
Devices
[edit]A double-lumen endotracheal tube (DLT) is used to isolate each lung. This allows one lung to be ventilated while the other lung is lavaged. The DLT has two separate lumens for independent lung ventilation and lavage.It ensures that the patient maintains adequate oxygenation during the procedure, as one lung remains functional while the other is being washed[8]
Adverse effects
[edit]Whole lung lavage (WLL) is a relatively safe procedure when performed by experienced medical teams, but it carries some risks and potential adverse effects. Here are the main complications and adverse effects associated with WLL. During the procedure, one lung is ventilated while the other is being lavaged, which can temporarily reduce oxygenation. Hypoxemia and dypsnea is a common but usually manageable complication, and oxygen levels are closely monitored throughout the procedure[8]
Mechanism of action
[edit]Removal of Accumulated Surfactant
[edit]In PAP, surfactant proteins and lipids accumulate in the alveoli, impairing gas exchange and leading to respiratory insufficiency. WLL works by instilling large volumes of saline into the lung, which helps to dissolve and mobilize these accumulated materials. The saline, along with the dissolved surfactant, is then drained from the lung, effectively clearing the alveolar spaces.[13]
Restoration of Alveolar Function
[edit]By physically washing out the debris and excess surfactant, WLL restores the normal architecture of the alveoli. This improves their ability to facilitate gas exchange, leading to better oxygenation of the blood and overall respiratory function[14]
Reduction of Inflammatory Mediators
In addition to surfactant removal, WLL can help reduce the concentration of inflammatory mediators within the alveoli. This can be particularly beneficial in conditions involving lung inflammation, as it helps to alleviate the inflammatory response and promote healing of the lung tissue.[13]
Improvement of Lung Compliance and Oxygenation
The removal of excess material from the alveoli improves lung compliance (the ability of the lungs to expand and contract). This leads to more effective ventilation and better oxygenation of the blood. Patients often experience a significant improvement in symptoms such as shortness of breath following WLL[15]
History
[edit]In 1963, Dr. Jose Ramirez-Rivera at the Veterans’ Administration Hospital in Baltimore tried repeated instillation of normal saline by a transtracheal plastic catheter positioned in one lung at a time in a series of two patients. Aliquots of 100 mL of warmed saline were instilled at a rate of 50–60 drops per minute. This process was repeated four times a day for 2–3 weeks. This technique showed improvement in chest-X-ray, diffusion capacity and histo-pathological findings. It was a prolonged and distressing procedure. The technique was thought to be imperfect and therefore denounced by many physicians at that time. In 1964, Ramirez-Rivera used a double lumen endotracheal tube (DLT) to isolate each lung, instilling up to 3 L saline containing heparin or acetylcysteine. This trial provided evidence that such a procedure was safe and feasible. Over the next four decades, the procedure has been further refined using general anesthesia, increased lavage volumes use of saline alone and by performing bilateral sequential WLL in the same treatment session[8]
See also
[edit]- Asbestosis
- Asthma
- Chronic obstructive pulmonary disease
- COVID-19
- Lavage
- Lung cancer
- Mesothelioma
- Pneumoconiosis
- Silicosis
References
[edit]- ^ Michaud, G.; Reddy, C.; Ernst, A. (2009). "Whole-lung lavage for pulmonary alveolar proteinosis". Chest. 136 (6): 1678–1681. doi:10.1378/chest.09-2295. PMID 19995769.
- ^ a b c d Cleveland Clinic (6 August 2014). "How 'Lung Washing' Helps You Breathe Again". HealthEssentials. Archived from the original on 14 August 2020. Retrieved 25 March 2020.
- ^ Patel, Pujan H.; Antoine, Marsha H.; Ullah, Saad (2023). "Bronchoalveolar Lavage". StatPearls. StatPearls Publishing. PMID 28613513.
- ^ a b Prudon, B; Attanoos, R; Morgan, C; Stenton, Sc (December 2012). "P112 Therapeutic Whole Lung Lavage For Silicosis – First Application in the UK". Thorax. 67 (Suppl 2): A111.1–A111. doi:10.1136/thoraxjnl-2012-202678.395. S2CID 72695608.
- ^ Danel, C.; Israël-Biet, D.; Costabel, U.; Klech, H. (1992). "Therapeutic applications of bronchoalveolar lavage". European Respiratory Journal. 5 (10): 1173–5. doi:10.1183/09031936.93.05101173. PMID 1486961. S2CID 6265382.
- ^ Chen, Y; Lyu, X; Li, T; Wang, H (22 September 2023). "Impact of Whole Lung Lavage on Pneumoconiosis Patients - China, 2018-2022". China CDC Weekly. 5 (38): 844–848. doi:10.46234/ccdcw2023.160. PMC 10560373. PMID 37814649.
- ^ Zeng Y, Jiang Y, Banks DE (August 2022). "The Effectiveness of Whole Lung Lavage in Pneumoconiosis: A Systematic Review and Meta-Analysis". J Occup Environ Med. 64 (8): e492 – e499. doi:10.1097/JOM.0000000000002599. PMID 35732044. S2CID 249956633.
- ^ a b c d Awab, Ahmed; Khan, Muhammad S.; Youness, Houssein A. (June 2017). "Whole lung lavage—technical details, challenges and management of complications". Journal of Thoracic Disease. 9 (6): 1697–1706. doi:10.21037/jtd.2017.04.10. ISSN 2072-1439. PMC 5506114. PMID 28740686.
- ^ Hilgendorff, Anne; Aslan, Ece; Schaible, Thomas; Gortner, Ludwig; Baehner, Thorsten; Ebsen, Michael; Kreuder, Jochen; Ruppert, Clemens; Guenther, Andreas; Reiss, Irwin (2008-07-14). "Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS". BMC Pulmonary Medicine. 8 (1): 10. doi:10.1186/1471-2466-8-10. ISSN 1471-2466. PMC 2483254. PMID 18625067.
- ^ Shrestha, D; Dhooria, S; Munirathinam, GK; Sehgal, IS; Prasad, KT; Ram, B; Singh, H; Aggarwal, AN; Puri, GD; Muthu, V; Agarwal, R (2022). "How We Do It: Whole Lung Lavage". Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 39 (2): e2022017. doi:10.36141/svdld.v39i2.12884. PMC 9437756. PMID 36118542.
- ^ Mariani, Francesca; Salvaterra, Elena; Lettieri, Sara; De Silvestri, Annalisa; Corino, Alessandra; Bosio, Matteo; Fraolini, Elia; Piloni, Davide; Rodi, Giuseppe; Corsico, Angelo Guido; Campo, Ilaria (December 2022). "A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP)". Respiratory Research. 23 (1): 60. doi:10.1186/s12931-022-01982-2. PMC 8932062. PMID 35300687.
- ^ Yang, Mingyuan; Li, Baoping; Wang, Bin; Li, Lei; Ji, Yurong; Zhou, Yunzhi; Huang, Rui; Cheng, Qinghao (December 2022). "Lung injury induced by different negative suction pressure in patients with pneumoconiosis undergoing whole lung lavage". BMC Pulmonary Medicine. 22 (1): 152. doi:10.1186/s12890-022-01952-w. PMC 9034602. PMID 35459122.
- ^ a b c Awab, Ahmed; Khan, Muhammad S.; Youness, Houssein A. (June 2017). "Whole lung lavage—technical details, challenges and management of complications". Journal of Thoracic Disease. 9 (6): 1697–1706. doi:10.21037/jtd.2017.04.10. ISSN 2077-6624. PMC 5506114. PMID 28740686.
- ^ Manohar, Manisha; Bansal, Priyanka (2022-02-05). "Whole lung lavage in pulmonary alveolar proteinosis: anesthetic management and challenges". Ain-Shams Journal of Anaesthesiology. 14 (1): 15. doi:10.1186/s42077-022-00213-6. ISSN 2090-925X.
- ^ Galhenage, Janith; Weerasinghe, Buddhika; Dilesha, Wadasinghe; Constantine, Roshana; Gunasena, Bandu (2017-03-08). "Pulmonary alveolar proteinosis and first successful whole lung lavage in Sri Lanka: a case report". Journal of Medical Case Reports. 11 (1): 62. doi:10.1186/s13256-017-1218-2. ISSN 1752-1947. PMC 5341169. PMID 28270188.